Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature

Abstract

Background: There are increasing reports describing invasive pulmonary aspergillosis (IPA) in patients with chronic obstructive pulmonary disease (COPD) without the classic risk factors for this severe infection. The available literature on this association is based on case reports or small case series. The aim of this review is to systematically review these cases and describe the clinical features, diagnostic studies and outcome.

Methods: We identified all the cases of IPA and COPD reported in the literature and had enough clinical information. We also included five cases of IPA in patients with COPD identified by the authors. These cases were systematically reviewed for clinical features, diagnostic studies and outcome.

Results: There were 60 cases of IPA in patients with COPD identified from the literature. The total number of cases reviewed was 65. The mean age was 65.1 years, the mean FEV1 was 39% of predicted (n = 17, range 19—56%). Forty-nine patients were documented to be on systemic corticosteroids. The mean dose was 24mg/day (range 15—65 mg/day). Five patients were only on inhaled corticosteroids and in 11 patients there was no documentation of corticosteroid therapy. The clinical and radiological findings were nonspecific. Thirteen patients had documented evidence of disseminated IPA. Sputum examination was positive for Aspergillus in 76% and bronchoscopy with bronchoalveolar lavage that was positive in 70%. The diagnosis of IPA was definite in 43 patients and probable in 22 patients. Forty-six patients were treated with anti-fungal therapy. Fifty-nine patients (91%) died with IPA.

Conclusion: Invasive pulmonary aspergillosis is an emerging serious infection in patients with COPD. The majority of these patients have advanced COPD and/or on corticosteroid therapy. The clinical and radiological presentation is nonspecific. High index of suspicion is necessary for the timely treatment of these patients. Chronic Respiratory Disease 2008; 5: 19—27

Keywords

aspergillosis COPD outcome pulmonary fungal infections

References

Rankin NE Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy. Br Med J 1953; 1: 918—9.

Groll AH , Shah PM , Mentzel C. , Schneider M. , Just-Nuebling G. , Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23—32.

Soubani AO , Chandrasekar PH The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121: 1988—99.

Ader F. , Nseir S. , Le Berre R. et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005; 11: 427—9.

Carrascosa Porras M. , Herreras Martinez R. , Corral Mones J. , Ares Ares M. , Zabaleta Murguiondo M. , Ruchel R. Fatal Aspergillus myocarditis following short-term corticosteroid therapy for chronic obstructive pulmonary disease. Scand J Infect Dis 2002; 34: 224—7.

Bulpa PA , Dive AM , Garrino MG et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001; 27: 59—67.

Vandewoude KH , Blot SI , Benoit D. , Colardyn F. , Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence . J Hosp Infect 2004; 56: 269—76.

Meersseman W. , Vandecasteele SJ , Wilmer A. , Verbeken E. , Peetermans WE , Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621—5.

Vandewoude KH , Blot SI , Depuydt P. et al. Clinical relevance of aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006; 10: 31.

10.

Ascioglu S. , Rex JH , de Pauw B. et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7—14.

11.

Rello J. , Esandi ME , Mariscal D. , Gallego M. , Domingo C. , Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26: 1473—5.

12.

Pittokopitis K. , Herriott DT , Shirey JK Massive fatal hemoptysis secondary to invasive aspergillosis in a patient with COPD. Chest 1983; 83: 583.

13.

Wiest PM , Flanigan T. , Salata RA , Shlaes DM , Katzman M. , Lederman MM Serious infectious complications of corticosteroid therapy for COPD. Chest 1989; 95: 1180—4.

14.

Kimmerling EA , Fedrick JA , Tenholder MF Invasive aspergillus niger with fatal pulmonary oxalosis in chronic obstructive pulmonary disease. Chest 1992; 101: 870—2.

15.

Ali ZA , Ali AA , Tempest ME , Wiselka MJ Invasive pulmonary aspergillosis complicating chronic obstructive pulmonary disease in an immunocompetent patient. J Postgrad Med 2003; 49: 78—80.

16.

Beckers EA , Strack van Schijndel RJ Aspergillus spondylodiskitis in a patient with chronic obstructive pulmonary disease. Eur J Intern Med 2002; 13: 139—42.

17.

Martinez M. , Lee AS , Hellinger WC , Kaplan J. Vertebral Aspergillus osteomyelitis and acute diskitis in patients with chronic obstructive pulmonary disease. Mayo Clin Proc 1999; 74: 579—83.

18.

Barouky R. , Badet M. , Denis MS , Soubirou JL , Philit F. , Guerin C. Inhaled corticosteroids in chronic obstructive pulmonary disease and disseminated aspergillosis. Eur J Intern Med 2003; 14: 380—2.

19.

Thommi G. , Bell G. , Liu J. , Nugent K. Spectrum of invasive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary disease. South Med J 1991; 84: 828—31.

20.

Kistemann T. , Huneburg H. , Exner M. , Vacata V. , Engelhart S. Role of increased environmental Aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit. Int J Hyg Environ Health 2002; 204: 347—51.

21.

Conesa D. , Rello J. , Valles J. , Mariscal D. , Ferreres JC Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother 1995; 29: 1235—7.

22.

Pittet D. , Huguenin T. , Dharan S. et al. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 541—4.

23.

Tankanow L. , Eichenhorn MS Disseminated Strongyloides stercoralis and Aspergillus fumigatus presenting as diffuse interstitial pneumonitis in a steroid-dependent chronic obstructive pulmonary disease patient. Henry Ford Hosp Med J 1988; 36: 41—3.

24.

Zarabi MC , Salmassi S. Antemortem diagnosis of systemic aspergillosis: ten-year review and report of a case. South Med J 1984; 77: 584—8.

25.

Palmer LB , Schiff MJ Rapidly progressive pneumonia in a patient with chronic obstructive pulmonary disease. Chest 1989; 95: 179—80.

26.

Rodrigues J. , Niederman MS , Fein AM , Pai PB Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992; 93: 29—34.

27.

Clancy CJ , Nguyen MH Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998; 114: 629—34.

28.

Dimopoulos G. , Piagnerelli M. , Berre J. , Eddafali B. , Salmon I. , Vincent JL Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003; 15: 71—5.

29.

Denning DW , Riniotis K. , Dobrashian R. , Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37: S265—80.

30.

Stuck AE , Minder CE , Frey FJ Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989; 11: 954—63.

31.

Balloy V. , Huerre M. , Latge JP , Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494—503.

32.

Denning DW Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 2001; 7: 25—31.

33.

Soubani AO , Khanchandani G. , Ahmed HP Clinical significance of lower respiratory tract Aspergillus culture in elderly hospitalized patients. Eur J Clin Microbiol Infect Dis 2004; 23: 491—4.

34.

Arnow PM , Andersen RL , Mainous PD , Smith EJ Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978; 118: 49—53.

35.

Fitzpatrick F. , Prout S. , Gilleece A. , Fenelon LE , Murphy OM Nosocomial aspergillosis during building work — a multidisciplinary approach. J Hosp Infect 1999; 42: 170—1.

36.

Madan T. , Eggleton P. , Kishore U. et al. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997; 65: 3171—9.

37.

Madan T. , Kishore U. , Singh M. et al. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun 2001; 69: 2728—31.

38.

Hawgood S. , Ochs M. , Jung A. et al. Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1002—10.

39.

Clark H. , Reid K. The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch Dis Child 2003; 88: 981—4.

40.

Wert SE , Yoshida M. , LeVine AM et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 2000; 97: 5972—7.

41.

Horvath JA , Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171—8.

42.

Treger TR , Visscher DW , Bartlett MS , Smith JW Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. J Infect Dis 1985; 152: 572—6.

43.

Yu VL , Muder RR , Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 1986; 81: 249—54.

44.

Nalesnik MA , Myerowitz RL , Jenkins R. , Lenkey J. , Herbert D. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 1980; 11: 370—6.

45.

Libshitz HI , Pagani JJ Aspergillosis and mucormycosis: two types of opportunistic fungal pneumonia . Radiology 1981; 140: 301—6.

46.

Kuhlman JE , Fishman EK , Burch PA , Karp JE , Zerhouni EA , Siegelman SS CT of invasive pulmonary aspergillosis. AJR Am J Roentgenol 1988; 150: 1015—20.

47.

Kuhlman JE , Fishman EK , Burch PA , Karp JE , Zerhouni EA , Siegelman SS Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management. Chest 1987; 92: 95—9.

48.

Kuhlman JE , Fishman EK , Siegelman SS Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985; 157: 611—4.

49.

Gaeta M. , Blandino A. , Scribano E. , Minutoli F. , Volta S. , Pandolfo I. Computed tomography halo sign in pulmonary nodules: frequency and diagnostic value. J Thorac Imaging 1999; 14: 109—13.

50.

Soubani AO , Qureshi MA Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect. Haematologia 2002; 32: 427—37.

51.

Levy H. , Horak DA , Tegtmeier BR , Yokota SB , Forman SJ The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992; 86: 243—8.

52.

Reichenberger F. , Habicht J. , Matt P. et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999; 24: 1195—9.

53.

Fischer JJ , Walker DH Invasive pulmonary aspergillosis associated with influenza. JAMA 1979; 241: 1493—4.

54.

Boots RJ , Paterson DL , Allworth AM , Faoagali JL Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax 1999; 54: 1047—9.

55.

Boutboul F. , Alberti C. , Leblanc T. et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis 2002; 34: 939—43.

56.

Marr KA , Balajee SA , McLaughlin L. , Tabouret M. , Bentsen C. , Walsh TJ Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641—9.

57.

Pfeiffer CD , Fine JP , Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417—727.

58.

Busca A. , Locatelli F. , Barbui A. et al. Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation . Transplant Proc 2006; 38: 1610—3.

59.

Musher B. , Fredricks D. , Leisenring W. , Balajee SA , Smith C. , Marr KA Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004; 42: 5517—22.

60.

Klont RR , Mennink-Kersten MA , Verweij PE Utility of Aspergillus antigen detection in specimens other than serum specimens . Clin Infect Dis 2004; 39: 1467—74.

61.

Salonen J. , Lehtonen OP , Terasjarvi MR , Nikoskelainen J. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. Scand J Infect Dis 2000; 32: 485—90.

62.

Hizel K. , Kokturk N. , Kalkanci A. , Ozturk C. , Kustimur S. , Tufan M. Polymerase chain reaction in the diagnosis of invasive aspergillosis. Mycoses 2004; 47: 338—42.

63.

Buchheidt D. , Baust C. , Skladny H. et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 2001; 33: 428—35.

64.

Loeffler J. , Kloepfer K. , Hebart H. et al. Polymerase chain reaction detection of aspergillus DNA in experimental models of invasive aspergillosis. J Infect Dis 2002; 185: 1203—6.

65.

Halliday C. , Hoile R. , Sorrell T. et al. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br J Haematol 2006; 132: 478—86.

66.

Johnson LB , Kauffman CA Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003; 36: 630—7.

67.

Ghannoum MA , Kuhn DM Voriconazole — better chances for patients with invasive mycoses. Eur J Med Res 2002; 7: 242—56.

68.

Herbrecht R. , Denning DW , Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408—15.

69.

Spanakis EK , Aperis G. , Mylonakis E. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis 2006; 43: 1060—8.

70.

Cohen-Wolkowiez M. , Benjamin DK Jr. , Steinbach WJ , Smith PB Anidulafungin: a new echinocandin for the treatment of fungal infections. Drugs Today (Barc) 2006; 42: 533—44.

71.

Herbrecht R. , Natarajan-Ame S. , Letscher-Bru V. , Canuet M. Invasive pulmonary aspergillosis. Semin Respir Crit Care Med 2004; 25: 191—202.

72.

Segal BH , Walsh TJ Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006; 173: 707—17.

73.

Caillot D. , Casasnovas O. , Bernard A. et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139—47.